WB6Dim digital well-being: 3-day test-retest
Psychometric Validation of Test-Retest Reliability of the WB6Dim Digital Self-Assessment Tool for Well-Being Using a 3-Day Interval Protocol and Contamination Control
This test checks whether the 28-item WB6Dim digital well-being questionnaire gives consistent results when French-speaking adults complete it twice, three days apart.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Clover Link Industry-sponsored |
| Locations | 1 site (Bandol) |
| Trial ID | NCT07433764 on ClinicalTrials.gov |
What this trial studies
Participants complete the 28-item WB6Dim at baseline (T1) and again three days later (T2) to measure test-retest reliability across eight well-being dimensions. A contamination-control question at T2 identifies pairs with significant life events, and those pairs are excluded from the primary intraclass correlation (ICC) analyses. The study targets 220 usable pairs to produce 95% confidence intervals with a maximum width of .20 for ICC estimates, improving precision over prior work. An optional third assessment at nine weeks (T3) provides exploratory data on sensitivity to change after access to a well-being program but is not part of the primary design.
Who should consider this trial
Good fit: Adults aged 18 or older who can read French, have internet access and an email address, and are willing to complete two short WB6Dim questionnaires three days apart are ideal candidates.
Not a fit: People who cannot read French, lack internet access, or who require a clinical diagnostic assessment rather than brief self-monitoring are unlikely to benefit from this protocol.
Why it matters
Potential benefit: If reliable, the WB6Dim could provide people and clinicians a quick, stable way to monitor multiple well-being dimensions digitally.
How similar studies have performed: A prior validation (N=295) showed strong internal consistency and convergent validity, and a 14-day test-retest (N=92) produced preliminary ICCs of .49 to .77, though the longer interval and limited pairs reduced confidence in those estimates.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older * Able to read and understand French * Access to an internet-connected device * Willing to complete the WB6Dim questionnaire at T1 and T2 * Consent to anonymous data collection for research purposes Exclusion Criteria: * Under 18 years of age * Unable to read or understand French
Where this trial is running
Bandol
- Clover Link — Bandol, France (Recruiting)
Study contacts
- Study coordinator: quentin ALITTA
- Email: quentin.alitta@gmail.com
- Phone: +33686505361
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.